coumestrol and Carcinoma

coumestrol has been researched along with Carcinoma* in 2 studies

Other Studies

2 other study(ies) available for coumestrol and Carcinoma

ArticleYear
Urinary phytoestrogen excretion of rats bearing methylnitrosourea-induced mammary carcinoma in response to treatment with 2-methoxyestradiol.
    The Journal of steroid biochemistry and molecular biology, 2007, Volume: 103, Issue:2

    The effect of treating mammary tumor-bearing rats with 2-methoxyestradiol (2-MeE2) on the urinary excretion of 12 phytoestrogens was investigated and compared with the changes in urinary excretion of estradiol metabolites. Alterations of excretion were registered for isoflavonoids, lignans and coumestans. However, due to large variations statistical significant differences were found only for two lignans, i.e. significant increases of enterodiol and matairesinol. Since the single components of phytoestrogens showed diverse alterations, excretions were expressed also by the ratio of total isoflavonoids to total lignans and compared with the estrogen ratios 2-hydroxyestrone to 16alpha-hydroxyestrone and A-ring to D-ring metabolites. The ratio of isoflavonoids to lignans was consistently decreased, whereas both ratios of estradiol metabolites were highly increased. The latter effect is probably due to demethylation of 2-methoxyestrone resulting in high catechol estrogen levels in urine. These results suggest that the high levels of catechol estrogens, produced by 2-MeE2 treatment, may have influenced the urinary excretion pattern of phytoestrogens.

    Topics: 2-Methoxyestradiol; Animals; Carcinoma; Coumestrol; Estradiol; Female; Isoflavones; Lignans; Mammary Neoplasms, Experimental; Methylnitrosourea; Phytoestrogens; Rats; Rats, Sprague-Dawley

2007
Histochemical analyses of steroid hormone receptors in breast and prostatic carcinoma.
    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 1980, Volume: 28, Issue:8

    Histochemical analyses estrogen (ER) and progesterone (PgR) receptors in breast cancer were statistically correlated with results of dextran-coated charcoal (DDC) and sucrose gradient assays. Correlated for ER was 91% of 363 cases, and for PgR 88% of 255 specimens. Breast cancer ER/PgR positivity by histochemistry correlated with a favorable clinical response to endocrine therapies in 72% of 25 cases, while ER/PgR negativity correlated with a lack of response in 96% of 22 cases with Stage IV disease. Nuclear ER/PgR correlated with a poor response to therapy in 8 of 12 patients. An in vitro technique to detect nuclear translocation of ER revealed two groups of ER positive cases, with 11 of 17 exhibiting translocation and 6 not displaying translocation. In prostatic carcinoma, 72% of 65 men were positive for ER and/or androgen receptor. Comparison of specimens obtained without and with electrocautery revealed a preponderance of nuclear binding in the latter, suggesting heat-induced nuclear translocation of receptor. coumestrol, a naturally fluorescent, entirely unaltered estrogen was also used for histochemical detection of ER. Results correlated with ER by DCC in 87% of 61 breast cancers. Coumestrol was additionally used to visually observe receptor and nuclear translocation of ER in intact whole cells in culture.

    Topics: Breast Neoplasms; Carcinoma; Coumestrol; Estrogens; Female; Histocytochemistry; Humans; Male; Progesterone; Prostatic Neoplasms; Receptors, Androgen; Receptors, Estrogen; Receptors, Steroid

1980